WoundSource
Published on WoundSource (https://www.woundsource.com)

Home > DermaPure® Decellularized Dermal Allograft

DermaPure® Decellularized Dermal Allograft [1]

DermaPure® is 99% DNA-free decellularized dermal allograft with vascular-like channels and an intact ECM necessary to signal a cellular response to healing.

TRX Biosurgery [2]

TRX Biosurgery is an innovative company in the field of regenerative medicine. The potential technology applications can address clinical needs such as wound care, vascular disease, heart valve replacement and knee repair.

Website: 
www.tissueregenixus.com
Email: 
enquiries@tissueregenix.com
Phone: 
(210) 659-9353
Fax: 
(210) 659-9556
Benefits: 

• Produced using patented dCELL® Technology
• Human-derived dermal allograft
• Minimally manipulated to maintain structure
• 99% DNA-free
• Biocompatible while retaining native growth factors, collagen and elastin, preserving natural structure
• Replaces the damaged extracellular matrix so living cells can flourish
• Supports angiogenesis with the presence of vascular-like channels present prior to application
• Permits fibroblasts to attach to the scaffold
• Contains the correct extracellular matrix components to attract and proliferate endothelial cells

Indications: 

DermaPure® Decellularized Dermal Allograft provides a scaffold for the body’s repair or replacement of damaged or inadequate integumental tissue or for other homologous uses of human integument.

Warnings and Precautions: 

See package insert/Instructions for Use.

Adverse Effects/Reactions: 

See package insert/Instructions for Use.

Storage Requirements: 

Ambient temperature.

Active Ingredients: 

Decellularized human dermis

How Supplied/Sizing: 
1cmx2cm, 2cmx2cm, 2cmx3cm, 3cmx4cm, 4cmx6cm, 7cmx10cm.
HCPCS Code (text): 
Q4152
Recommended Use: 

Acute Wounds
Burns
Cavity Wounds
Chronic Wounds
Deep Wounds
Dehisced Wounds
Diabetic Foot
Granulating/Epithelializing Wounds
Infected Wounds
Moderate/Highly Exudating Wounds
Non/Minimally Exudating Wounds
Palliative Wounds
Pressure Ulcers
Superficial Wounds
Surgical Wounds
Venous Ulcers

Removal & Change Frequency: 

Single application in most cases. Additional applications at physician discretion.

Additional Recommended Dressings: 

Primary dressing: Non-adherent contact layer. Bolster, first five to seven days post application: Normal saline-moistened gauze or hydrogel-moistened gauze. Secondary dressing: Maintain a moist wound environment (e.g., foam dressing).

Product features: 
Assigned HCPCS code●
Cryopreserved
Dehydrated
Desiccated
Flowable
Micronized
Sheet form●
Requires refrigeration
Shelf life greater than 2 years●
Shelf life limited
Indicated for acute wounds●
Indicated for chronic wounds●
Indicated for diabetic ulcers●
Indicated for pressure ulcers●
Indicated for surgical wounds●
Indicated for third-degree burns●
Indicated for venous ulcers●
Contact manufacturer for usage guidelines●
Other features: 
Educational Material Available●
Free Samples/Trials Available●
Published Clinical Article Available●
© 2008-2019 Kestrel Health Information, Inc. All rights reserved.

Source URL (modified on 2019-05-19 10:37): https://www.woundsource.com/product/dermapure-decellularized-dermal-allograft

Links
[1] https://www.woundsource.com/product/dermapure-decellularized-dermal-allograft
[2] https://www.woundsource.com/company/trx-biosurgery